OS Therapies Inc’s (NYSE:OSTX) Quiet Period Set To Expire on September 10th

OS Therapies’ (NYSE:OSTX) quiet period will expire on Tuesday, September 10th. OS Therapies had issued 1,600,000 shares in its IPO on August 1st. The total size of the offering was $6,400,000 based on an initial share price of $4.00. During the company’s quiet period, underwriters and any insiders that worked on the IPO are prevented from issuing any earnings forecasts or research reports for the company because of SEC regulations. Following the expiration of the company’s quiet period, the brokerages that served as underwriters will likely initiate research coverage on the company.

Wall Street Analyst Weigh In

A number of research analysts recently weighed in on the stock. EF Hutton Acquisition Co. I raised shares of OS Therapies to a “strong-buy” rating in a research report on Tuesday. Brookline Capital Management raised shares of OS Therapies to a “strong-buy” rating in a research report on Thursday, August 22nd.

OS Therapies Stock Up 4.5 %

Shares of NYSE:OSTX opened at $4.18 on Friday. OS Therapies has a fifty-two week low of $2.51 and a fifty-two week high of $4.90.

OS Therapies (NYSE:OSTX) last released its earnings results on Wednesday, August 14th. The company reported ($0.26) earnings per share for the quarter. On average, analysts predict that OS Therapies will post -0.47 earnings per share for the current fiscal year.

About OS Therapies

OS Therapies Incorporated is a clinical stage biopharmaceutical company focused on the identification, development and commercialization of treatments for Osteosarcoma (OS) and other solid tumors. Our mission is to address the significant need for new treatments in cancers of the bone in children and young adults.